The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 13, 2021
Filed:
Aug. 01, 2018
Applicant:
Aleta Biotherapeutics Inc., Natick, MA (US);
Inventors:
Roy Lobb, Wellesley, MA (US);
Paul Rennert, Holliston, MA (US);
Assignee:
Aleta Biotherapeutics Inc., Natick, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/32 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 16/30 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C07K 16/32 (2013.01); A61K 38/177 (2013.01); A61K 38/1774 (2013.01); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001112 (2018.08); A61K 39/001166 (2018.08); A61K 39/395 (2013.01); A61K 39/39558 (2013.01); A61K 47/646 (2017.08); A61K 47/6803 (2017.08); A61K 47/6839 (2017.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 14/70503 (2013.01); C07K 14/70578 (2013.01); C07K 14/71 (2013.01); C07K 16/30 (2013.01); C12N 5/0636 (2013.01); C12N 15/86 (2013.01); A61K 2039/507 (2013.01); A61K 2039/5156 (2013.01); C07K 14/70596 (2013.01); C07K 2317/622 (2013.01); C07K 2317/732 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01); C07K 2319/74 (2013.01); C12N 2510/00 (2013.01); C12N 2750/14143 (2013.01);
Abstract
The invention relates to cancer therapeutics, in particular, the system of making cancer cells more susceptible to effector cells by introduction of cellular therapy targets into the cancer cells.